Regenesis Biomedical takes to the stage at the AdvaMed 2011 MedTech

Regenesis Biomedical to Participate in the AdvaMed 2011 MedTech Conference:  Selected to present in the Wound Management category and serve as a panelist on Emerging Growth Companies.

Scottsdale, Arizona, September 5, 2011 — Regenesis Biomedical, Inc., a medical technology company focused on regenerative medicine, announced today that it was selected to present at the AdvaMed 2011 MedTech conference. Regenesis presents in the Wound Management category. The aim of the conference is to connect companies that have an innovative medical technology to parties interested in investing capital, partnering, or initiating strategic alliances.Continue reading

Life Sciences in the Fast Lane

MP900438890[1]This year at the AZBio Awards and Expo our theme is all about forward motion.  Specifically, how  we move forward…faster.

From global innovations like IBM’s WATSON on Thursday night October 13, 2011 to panels of CEOs and leaders along with  nationally recognized thought leaders who will take the stage Friday October 14, 2011,  the conversations are geared up to deliver  the information and ideas  we  need to move our industry and our economy forward…faster.

A single accelerator? Continue reading

Roche Appoints Mara G. Aspinall President of Ventana Medical Systems, Inc.

VENTANA MEDICAL SYSTEMS, INC. President MARA ASPINALL
TUCSON, Ariz., Aug. 1, 2011 /PRNewswire/ — Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today the appointment of Mara Aspinall to the role of President, Ventana Medical Systems, Inc.  Aspinall was most recently Founder, President, and CEO of On-Q-ity, a start-up diagnostics company focused on circulating tumor cell technology.  Continue reading

We want to know your name

Biotechnology is changing the way we live, how we think about health, how we combat disease, how we create a more sustainable planet and so much more.  It’s an exciting field in an exciting time and Arizona is a place where bioscience companies, research institutions, and the companies that support them come to  engage, connect, collaborate and grow.

Continue reading

First Things First

In an industry like ours, doing things in the right order matters.  It does not matter of you are working in the lab, biz dev or the front office.  When you forget to put first things first you might not get the outcome you expect…or need.

At AZBio we have been investing our time in research.  For us that means getting out of the office and into the  community to talk to Members, create opportunities to connect and to listen to what they have to say.  Whether we are are in one-on-one visits to Members and their companies, meetings at the GPEC, The Desert Angels or BCLSA or hanging out with the AZBio Gang at Beer and Bio, we’ve been asking questions and gathering data on what you, our members want and need.   So far this research has led to some new developments and there are a lot more coming,  Here are FIVE important things you said…Continue reading

AZBio News for March 2011

Apthera and RXi Pharmaceuticals Announce Definitive Merger Agreement

Ventana Medical Launches Virtuoso Software for Digital Pathology

Catalyst for Growth – AZ Bio moves forward with new CEO and an aggressive agenda

Gore Reports First Patient Treated in the U.S. using GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface on a Lower Profile Delivery System

MSDx Awarded $226,000 Arizona Commerce Authority Grant

AdvaMed Appoints Regenesis Biomedical Chief Executive to Board of Directors